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Abstract
Previous studies have demonstrated that maternal ethanol exposure induces a moderate increase in Nrf2 protein expression
in mouse embryos. Pretreatment with the Nrf2 inducer, 3H-1, 2-dithiole-3-thione (D3T), significantly increases the Nrf2
protein levels and prevents apoptosis in ethanol-exposed embryos. The present study, using PC12 cells, was designed to
determine whether increased Nrf2 stability is a mechanism by which D3T enhances Nrf2 activation and subsequent
antioxidant protection. Ethanol and D3T treatment resulted in a significant accumulation of Nrf2 protein in PC 12 cells. CHX
chase analysis has shown that ethanol treatment delayed the degradation of Nrf2 protein in PC12 cells. A significantly
greater decrease in Nrf2 protein degradation was observed in the cells treated with D3T alone or with both ethanol and
D3T. In addition, D3T treatment significantly reduced ethanol-induced apoptosis. These results demonstrate that the
stabilization of Nrf2 protein by D3T confers protection against ethanol-induced apoptosis.
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Introduction
Maternal consumption of alcohol during pregnancy results in a
range of structural and functional birth defects. Fetal Alcohol
Spectrum Disorders (FASD) is an umbrella term describing the
range of effects that can occur in an individual whose mother
drank alcohol during pregnancy. Prenatal alcohol exposure is
considered to be the leading known non-genetic cause of mental
retardation in the Western world [1,2].
Studies using both rodent and avian animal models have shown
that the vulnerability of selected cell populations to ethanol-
induced apoptosis is a major component in the pathogenesis of
ethanol-induced malformations [3–8]. Excessive cell death was
found in specific regions of the brain of gestational day 8.5 to 9
ethanol-exposed mouse embryos [6,7]. Among the vulnerable cell
populations are cranial neural crest cells (NCCs) [3,4,7,9]. In
addition, ethanol exposure during the period of brain development
resulted in the death of neurons in the hypothalamus [10], cerebral
cortex [11], cerebellum [12], and associated brain–stem structures
[13]. The ethanol-induced cell death in embryos has been shown
to be apoptotic [5,6,11,14,15].
Among a number of mechanisms underlying ethanol-induced
apoptosis and subsequent malformations is oxidative stress
[4,5,15–19]. Reactive oxygen species (ROS) generation has been
observed in mouse embryos exposed to ethanol both in vitro and in
vivo [5,16,18]. Antioxidants have been shown to diminish ethanol-
induced superoxide anion generation, lipid peroxidation and cell
death, as well as the incidence of neural tube defects in cultured
mouse embryos [18]. In vivo studies have also shown that ethanol-
induced apoptosis in selected cell populations in the developing
limb buds and subsequent limb defects can be partially prevented
by maternal treatment with an SOD and catalase mimetic, EUK-
134 [15]. However, while antioxidants are promising for human
application, the incomplete protection provided by exogenous
antioxidants points to the limitations associated with the use of
exogenous antioxidants. Therefore, a strategy for protecting
against oxidative injury through the upregulation of endogenous
antioxidants holds significant promise for the prevention of
FASD.
Recently, Nrf2 has been demonstrated to be a key transcription
factor that regulates the induction of antioxidant genes [20,21].
Under basal conditions, Nrf2 is mainly in the cytoplasm through
binding to Kelch-like ECH-associated protein 1 (Keap1), which in
turn facilitates the ubiquitylation and subsequent proteolysis of
Nrf2 in a constitutive manner [22–25]. In response to oxidative
stress, Nrf2 dissociates from Keap1, translocates into the
nucleus and elicits the antioxidant response by induction of a
battery of gene products, including antioxidant and phase II
detoxification enzymes [26,27]. It has been suggested that activa-
tion of Nrf2 is dependent on the mechanisms that increase its
stability [28,29].
There are a numbers of natural and synthetic small molecules
that can induce Nrf2 activation [30–32]. Among these potent Nrf2
inducers are isothiocyanates, tert-butylhydroquinone (tBHQ) and
1,2-dithiole-3-thiones (D3T) [32–34]. D3T is a potent cancer
chemopreventive agent that prevents against mutation and
initiation of neoplasia [35]. Activation of the Nrf2 pathway by
oral administration of D3T has also been reported to confer partial
protection against MPTP-induced neurotoxicity [36]. The pro-
tective effects of D3T have been associated with induction of the
detoxifying and antioxidant enzymes SOD, catalase and c -
glutamylcysteine synthetase (c - GCS) [32,35,37].
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ethanol treatment resulted in increased Nrf2 protein levels and
Nrf2-ARE binding in mouse embryos. Maternal ethanol exposure
also resulted in a moderate increase in the mRNA and protein
expression of Nrf2 downstream target antioxidant genes. Pretreat-
ment with D3T significantly increased Nrf2 protein levels and
Nrf2-ARE binding, and strongly induced the mRNA and protein
expression of Nrf2 downstream target genes. In addition, D3T
pretreatment resulted in a significant decrease in ROS generation
and apoptosis in ethanol-exposed embryos [16]. These results
support the hypothesis that Nrf2 signaling is involved in induction
of an antioxidant response in ethanol-exposed mouse embryos.
Although the in vivo study using intact embryos has clearly
demonstrated that D3T can induce Nrf2 activation and prevent
ethanol-induced oxidative stress and apoptosis, the mechanisms by
which D3T enhances Nrf2-mediated transcriptional activation
and subsequent antioxidant protection remain elusive. Using
PC12 cells, a cell line derived from the neural crest, as an in vitro
model, the current study was designed to elucidate the
mechanisms underlying D3T mediated Nrf2 activation and
subsequent antioxidant protection in ethanol-exposed neural crest
cells and other developing neuronal cells. The results of this study
support the hypothesis that the stabilization of Nrf2 protein by
D3T is one of the important mechanisms underlying D3T-
mediated Nrf2 activation and antioxidant protection against
ethanol-induced apoptosis in PC12 cells.
Results
Ethanol exposure and D3T treatment significantly
increased Nrf2 protein expression in PC12 cells
To determine whether ethanol exposure can increase the Nrf2
protein levels, PC 12 cells were treated with 200 mM ethanol for
48 hours and the Nrf2 protein level was determined by western
blot. As shown in Fig. 1, ethanol exposure resulted in a 15-fold
increase in the Nrf2 protein levels. To examine the effects of D3T
on Nrf2 protein expression, PC 12 cells were pretreated with
50 mM D3T for 16 hours, following concurrent exposure to D3T
and ethanol for 48 hours. Treatment of PC12 cells with D3T
alone showed a 25-fold increase in Nrf2 protein levels as compared
to the control group. The combination of the D3T treatment and
ethanol exposure yielded an increase in Nrf2 protein expression
that is comparable to that in the cells treated with D3T alone.
These results indicate that while both ethanol and D3T can
increase Nrf2 protein expression, D3T treatment resulted in a
significantly greater increase in Nrf2 levels in control and ethanol-
exposed PC 12 cells.
Treatment with ethanol and D3T delayed the
degradation of Nrf2 protein in PC12 cells
To determine the effects of ethanol and D3T on Nrf2 protein
stability, CHX chase analysis was performed in PC 12 cells. Cells
were pretreated with the proteasome inhibitor, MG132 for
3 hours to inhibit the proteasomal degradation of Nrf2. The cells
were then treated for 2 hours with CHX alone or along with either
ethanol, D3T, or ethanol plus D3T. A significant increase in Nrf2
protein expression was observed in MG132-treated PC 12 cells,
suggesting that Nrf2 protein is degraded by the proteasome in
PC12 cells. CHX chase analysis has shown that ethanol treatment
delayed the degradation of Nrf2 protein in PC12 cells. A
significantly greater decrease in Nrf2 protein degradation was
observed in PC 12 cells treated with D3T alone or co-treated with
both ethanol and D3T (Fig. 2), indicating that D3T can
significantly increase Nrf2 protein stability in PC12 cells.
D3T treatment significantly prevented apoptosis in
ethanol-exposed PC12 cells
In recognizing that excessive apoptosis is a prominent patho-
genic feature in FASD models and that D3T induced Nrf2
activation can prevent apoptosis in mouse embryos exposed to
ethanol, the potential of D3T to diminish apoptosis in ethanol-
exposed PC12 cells was tested. Flow cytometric analysis revealed a
significant increase in apoptosis in the ethanol-exposed PC12 cells
as compared to the control cells. D3T treatment reduced the
apoptosis in ethanol-exposed PC12 cells to the level comparable to
that in control cells (Fig. 3).
Discussion
The vulnerability of selected cell populations, including neural
crest cells (NCCs), to ethanol-induced cytotoxicity is one of the
important factors that contribute to the genesis of alcohol-related
birth defects. NCCs are progenitors of multiple cell types,
including the skeletal and connective tissues of the face [38–40].
Ethanol has been shown to induce apoptotic cell death in NCCs, a
result that appears to contribute heavily to subsequent abnormal-
ities [3,4,7,41]. To elucidate the mechanisms underlying D3T-
mediated Nrf2 activation and subsequent protection against
ethanol-induced apoptosis in neural crest cells and other
developing neuronal cells, PC12 cells, a cultured rat pheochro-
mocytoma cell line, was used as an in vitro model. PC12 cells
appear to be a good model system to current study because these
cells are derived from the neural crest [42] and are commonly
utilized in the studies regarding the molecular and cellular
mechanisms of neuronal development. In addition, PC12 cells
have been used extensively to study the mechanisms underlying
ethanol-induced cell death [43–45]. In the present study, flow
cytometric analysis using an Annexin V-FITC Apoptosis Detec-
Figure 1. Treatment with ethanol and D3T increased the level
of Nrf2 protein in PC12 cells. Western blot was performed to
analyze the level of Nrf2 protein in PC12 cells. Cell lysates were
prepared from PC12 cells cultured in control medium (Control), treated
with 200 mM ethanol (EtOH), treated with 50 mM D3T alone (D3T), or
treated with both ethanol and D3T (EtOH+D3T). Data are expressed as
fold change over control and represent the mean 6 SEM of three
separate experiments. * p,0.05 vs. control.
doi:10.1371/journal.pone.0016845.g001
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exposed PC12 cells. These findings are consistent with previous
reports illustrating ethanol-induced cell death in PC12 cells [43–
45].
The role of Nrf2 in cell survival has been supported by a
number of studies. Fas-induced apoptosis has been shown to be
prevented by over-expression of Nrf2 [46]. Activation of Nrf2 was
also found to protect against nitric oxide-induced apoptosis [47] as
well as cell death in an in vitro model of ischemia/reperfusion [48].
Additionally, in response to elevated chromium (VI) and
cadmium, increased ROS production and apoptosis were
observed in mouse embryonic fibroblast cells lacking Nrf2
[49,50]. In this study, a chemical inducer of Nrf2, D3T, has been
shown to potently increase Nrf2 levels and significantly diminish
apoptosis in ethanol-exposed PC12 cells. These results are
consistent with a previous in vivo study showing that D3T can
diminish ethanol-induced apoptosis in early mouse embryos by
induction of Nrf2 [16]. The results also clearly demonstrate that
D3T is a potent Nrf2 inducer that can induce an antioxidant
response and prevent ethanol-induced apoptosis. However, in this
study, an increase in Nrf2 levels was also observed in PC12 cells
exposed to ethanol alone. The observed Nrf2 activation in PC12
cells exposed to ethanol alone was expected because exposure of
cells to ethanol results in the generation of ROS [51], which are
known to activate Nrf2 [26]. This response is not unique to
ethanol-exposed cells. Increases in Nrf2 levels have also been
observed in cells treated with a numbers of other toxic chemicals,
including heavy metals [49,52] and cigarette smoke [53], as well as
in the livers and hepatocytes of alcohol-fed mice and rats [54]. The
fact that excessive apoptosis results from the same ethanol
exposure regimen that increased Nrf2 levels suggests that the
ethanol-induced activation of Nrf2 is an adaptive response that is
insufficient to be protective. This is supported by the results from
the previous in vivo and in vitro studies showing that ethanol can
induce only a moderate increase in Nrf2 downstream antioxidant
and detoxifying gene expression [16,51].
Nrf2 is a highly unstable protein and its half-life is about 15 min
in untreated cells [20]. A well established mechanism that controls
Nrf2 activation is that oxidative stress or Nrf2 inducers can
increase Nrf2 protein stability, resulting in its accumulation in the
cells [28,29]. The Keap1-Nrf2 complex appears to play critical
role in facilitating the degradation of Nrf2 [55–57]. It has been
suggested that ubiquitination of the cytoplasmic Nrf2 involves the
Keap1-Cul3-dependent E3. Keap1 functions as a BTB-containing
substrate adaptor protein for Cul3 and brings Nrf2 into the Cul3-
Rbx1 complex for ubiquitination [55–57]. However, the molec-
ular mechanisms underlying the stabilization of Nrf2 protein by
various exogenous Nrf2 inducers have not been clearly addressed.
Although D3T has long been of interest as an effective inducer
of Nrf2, the mechanisms underlying D3T mediated Nrf2
activation are not fully understood. Studies have suggested that
the interaction between D3T and the sulfhydryl groups of Keap1
can cause dissociation of Keap1 from Nrf2, leading to Nrf2
activation [58]. In addition, mitogen-activated protein kinases
(MAPKs) have recently been shown to be involved in the
activation of Nrf2 by D3T [59]. In this study, a significant
increase in Nrf2 protein levels was observed in MG132-treated
PC12 cells, suggesting that Nrf2 protein is degraded by the
proteasome in the cells. CHX chase analysis has shown that
ethanol treatment delayed the degradation of Nrf2 protein in
PC12 cells. A significantly greater decrease in Nrf2 protein
degradation was observed in PC12 cells treated with D3T alone or
Figure 3. Flow cytometry of apoptotic PC12 cells with Annexin
V-FITC showed that D3T treatment significantly prevents
ethanol-induced apoptosis. Apoptosis was measured in PC12 cells
cultured in control medium (Control), treated with 200 mM ethanol
(EtOH), treated with 50 mM D3T alone (D3T), or treated with both
ethanol and D3T (EtOH+D3T). Data are expressed as fold change over
control and represent the Mean 6 SEM of three separate experiments.
*p,0.05 vs. control. #p,0.05 vs. EtOH.
doi:10.1371/journal.pone.0016845.g003 Figure 2. CHX chase analysis showed that treatment with
ethanol and D3T delayed the degradation of Nrf2 protein in
PC12 cells. Western blot was performed to analyze the level of Nrf2
protein in PC12 cells. Cell lysates were prepared from PC12 cells
cultured in control medium (lane 1), treated with proteasome inhibitor
MG132 (30 mM) for 3 hrs (lane 2), treated with MG132 for 3 hrs,
followed by treatment for 2 hrs with CHX (an inhibitor of protein
synthesis,100 mg/ml) alone (lane 3), or CHX along with either 200 mM
ethanol (lane 4), 50 mM D3T (lane 5), or ethanol plus D3T (lane 6). Data
are expressed as fold change over control and represent the mean 6
SEM of three separate experiments. * p,0.05 vs. group treated with
MG132 and CHX (lane 3).
doi:10.1371/journal.pone.0016845.g002
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D3T induces Nrf2 activation in PC12 cells by enhancing Nrf2
stability, resulting in elevated Nrf2 levels, and ultimately induction
of Nrf2-ARE-dependent gene transcription.
In conclusion, the results of the current study demonstrate that
increased Nrf2 protein stability is a mechanism underlying D3T-
mediated Nrf2 activation, ultimately leading to an enhanced
protection against ethanol-induced apoptosis in PC12 cells. These
results, along with the findings from a previous study showing that
D3T can induce an antioxidant response and prevent ethanol-
induced apoptosis in early mouse embryos by induction of Nrf2,
support the potential of Nrf2 inducers in attenuating oxidative
tissue damage and in conferring in vivo protection against a variety
of ROS related disease and disorders, including FASD.
Materials and Methods
Cell Culture and Treatments
PC12 cells (American Type Culture Collection, Rockville, MD,
USA) were cultured in Dulbecco’s modified Eagle’s medium
(DMEM) (Invitrogen, Carlsbad, CA, USA) supplemented with
10% horse serum, 5% fetal bovine serum (FBS), 100 kU/L of
penicillin, and 100 mg/L of streptomycin (Sigma, St. Louis, MS,
USA) at 37uC with a 5% CO2 atmosphere in a humidified
incubator. For D3T pretreatment, PC 12 cells were treated with
50 mM D3T alone for 16 hours, followed by 48 hours of
concurrent exposure to D3T and 200 mM ethanol. For ethanol
treatment, the cells were cultured in medium containing 200 mM
ethanol for 48 hours. Stable ethanol levels were maintained by
placing the cell culture plates in a plastic desiccator containing
300 ml of 200 mM ethanol in distilled water. The ethanol
concentration in the medium was measured using Analox Alcohol
Analyzer (Model AM1, Analox Instruments USA Inc, Lunenburg,
MA, USA).
Protein Degradation Assay
Nrf2 protein degradation was analyzed by CHX-chase analysis.
The PC12 cells were pretreated with proteasome inhibitor MG132
(30 mM) for 3 hours to initially inhibit the proteosomal degrada-
tion of Nrf2, leading to the accumulation of Nrf2 for degradation
studies. Following extensive washing with fresh media to remove
the inhibitor, the cells will then be treated for 2 hours with
cycloheximide (CHX, an inhibitor for protein synthesis, 100 mg/
ml) alone or along with either 200 mM ethanol, 50 mM D3T, or
ethanol plus D3T. Nrf2 protein levels were analyzed by Western
blot.
Western Blotting
PC12 cells were washed in phosphate-buffered saline (PBS) and
lysed for 30 min in RIPA lysis buffer (PBS, 0.5% Sodium
Deoxycholate, 1% NP-40, 0.1% SDS, 1 mM Dithiothreitol) with
1 mM PMSF and protease cocktail inhibitors (Roche, Applied
Science, Indianapolis, IN, USA). The samples were then centrifuged
at 16,000 g for 10 min at 4uC. The supernatants were collected for
Western blotting. Western blots were performed by standard
protocolsas described previously[5]. Briefly, the protein was resolved
on an SDS-10% polyacrylamide gel and transferred to nitrocellulose
membranes. The levels of Nrf2 were analyzed with rabbit polyclonal
anti-Nrf2 IgG (1:500, Santa Cruz, Santa Cruz, CA, USA), followed
by detection with ECL plus western blotting detection reagents (GE
Healthcare, Piscataway, NJ, USA). The membranes were then
scanned on a Bio-Rad Versa DocTM Imaging System (Model 4000)
and the intensity of the protein bands was analyzed using the Bio-Rad
Quantity One software (Version 4.5.1).
Flow-Cytometric Analysis of Apoptosis
Analysis of apoptosis was performed using an Annexin V-FITC
Apoptosis Detection Kit (BD Bioscience, San Jose, CA, USA)
according to the manufacturer’s instructions. PC12 cells were
washed twice with PBS and then resuspended in 1X binding buffer
at a concentration of 1610
6 cells/ml. Then 100 ml of the solution
(1610
5 cells) was transferred to a 5 ml tube and 5 ml of Annexin V
was added into the tube. The cells were incubated for 15 min at
room temperature in the dark and then analyzed in a Dako CyAn
flow cytometer (Beckman-Coulter Dako CyAn ADP).
Statistical Analysis
Statistical analyses were performed using StatView software
(SAS Institute Inc, Cary, NC, USA). Data are expressed as mean
6 SEM of three separate experiments. Statistical comparisons
between groups were analyzed by a One-way ANOVA. Multiple
comparison post-tests between groups were conducted by using
Bonferroni’s test. Differences between groups were considered
significant at p,0.05.
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